Warren L. DeSouza, Chief Financial Officer at Aimmune Therapeutics, Inc. (AIMT), sold 15,000 shares at $21.58 ($324K) on 2017-04-03, disclosed to the SEC on 2017-04-05.
Open-market sale of $324k AIMT by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.